ReviewPoultry science2026
Establishing food-safe cell lines and banks for cultivated meat: current status and future directions.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cultivated meat has emerged as a promising complement to conventional livestock production, with the potential to contribute to food security, animal welfare, and more sustainable food systems. As the field advances toward commercial-scale manufacturing, ensuring product safety and consistency depends fundamentally on establishing well-characterized, stable, and food-safe cell lines and cell banking systems. Cell lines underpin cultivated meat production and serve as critical control points for hazards, including microbial contamination, adventitious agents, genomic instability, cell misidentification, and tumorigenic transformation. This review examines current scientific knowledge, regulatory developments, and industry practices related to cell line development and cell banking for cultivated meat production. Drawing on publicly available regulatory dossiers from GOOD Meat, UPSIDE Foods, and Vow Group, it systematically compares approaches to donor animal qualification, cell sourcing, adventitious agent testing, genomic stability assessment, tumorigenicity evaluation, and cell bank monitoring. The analysis reveals substantial variability in testing strategies, documentation practices, and safety assessment criteria, highlighting the absence of internationally harmonized food-grade standards for cell line qualification and banking. By integrating evidence from regulatory dossiers, scientific literature, and established biopharmaceutical guidance frameworks, this review identifies microbial contamination, adventitious agents, genomic instability, and tumorigenicity as priority hazards requiring systematic control. To address these challenges, a risk-based Food-Safe Cell Line and Banking Framework (FSCLBF) is proposed to support future standardization efforts. The development of transparent, affordable, and robust approaches for cell line qualification and banking will be essential for strengthening regulatory confidence, enhancing consumer trust, and supporting commercialization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.